Navigation Links
Folic acid for everybody -- arguments in favor of food fortification
Date:4/28/2011

Neural tube defects in neonates are common in Germany compared with the rest of Europe. Extensive folic acid fortification of foods in Germany might prevent these in 85-100% of cases, Wolfgang Herrmann and Rima Obeid argue in this issue of Deutsches rzteblatt International (Dtsch Arztebl Int 2011; 108[15]; 249-54).

A woman's folic acid intake before and during early pregnancy ensures that the fetus does not develop the neural tube defect commonly known as spina bifida. Every year, 800 pregnancies in Germany are diagnosed with a neural tube defect. Most of those pregnancies are terminated.

However, the mandatory fortification of foods with folic acid is subject of controversy in Germany. Overdosages of folic acid are suspected of accelerating the growth of certain cancers. Herrmann and Obeid evaluate different international studies and show that this suspicion is not supported by the evidence. No association was found, for example, for the observed increase in the number of patients with colorectal cancer after folic acid fortification programs started in the United States and Canada. According to Herrmann and Obeid, the increase can be explained by improved early detection programs during this time period.


'/>"/>

Contact: Dr. Rima Obeid
rima.obeid@uniklinikum-saarland.de
Deutsches Aerzteblatt International
Source:Eurekalert

Page: 1

Related medicine news :

1. No Heart Benefit Seen From Folic Acid Supplements
2. Some TV Fans Distressed Without Favorite Shows: Study
3. Parents favor genetic testing for melanoma in their children
4. Youth report favorable impressions of community street outreach workers
5. Right or left? Brain stimulation can change which hand you favor
6. Tumor budding identified as predictor for unfavorable outcome in lung cancer
7. Less Invasive Biopsies Gain Favor
8. Drug trials funded by industry are more likely to publish favorable results
9. Top Off Your Favorite Summer Treat with NOT JUST CEREAL™
10. Study confirms favorable long-term prognosis of epilepsy
11. The Pill Is Birth Control Favorite in U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... , ... October 13, 2017 , ... Yisrayl Hawkins, Pastor ... that explains one of the most popular and least understood books in the Holy ... and puzzling descriptions that have baffled scholars for centuries. Many have tossed it off ...
(Date:10/13/2017)... ... 13, 2017 , ... Coveros, a leader in agile coaching ... contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile ... of Agile methodologies in a consistent and high value manner across CMS programs. ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and ... of published author, William Nowers. Captain Nowers and his wife, Millie, have six ... years in the Navy. Following his career as a naval aviator and carrier ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and ... apnea using cutting-edge Oventus O2Vent technology. As many as 18 million Americans ... frequent cessation in breathing. Oral appliances can offer significant relief to about 75 ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company ... of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every ... meet the highest standard. , These products are also: Gluten Free, Non-GMO, ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... , Sept. 27, 2017  Commended for their devotion ... notable awards. Ranked as number one in the South Florida ... time in Inc. 5000 yearly list, the national specialty pharmacy ... Armando Bardisa will soon be honored by SFBJ ... Set to receive his award in ...
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
Breaking Medicine Technology: